pre-test 1.regargind latest guideline on initiation of arv start at cd4 of a. 200cc/ml c.. ...
TRANSCRIPT
![Page 1: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/1.jpg)
PRE-TEST
• 1.Regargind latest guideline on initiation of ARV start at CD4 of
• A. <200cc/ml
• B.>200cc/ml
• C..<350cc/ml
• D.<500cc/ml
• E. non of the above
• 2.Best ARVs combination for PMTCT should contain at least
• A. AZT
• B. 3TC
• C.TDF
• D.LPV/r
• E. NVP
![Page 2: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/2.jpg)
• 3.Best option advocated by the WHO IS
• A.Option a
• B. Option b
• C.Option c
• D. Option a+
• E. option b+
• 4. Factors associated with MTCH include
• A.low viral load
• B.infections
• C. prolong rupture of membranes
• D.cracked nipples
• E. antepartum haemorrhage
![Page 3: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/3.jpg)
• 5.concerning choice of ARVs for PMTCT
• A.NVP should be avoided in the first trimester
• B.EFZ can be use in the first trimester
• C.NVP is safe in TB/HIV Co infection
• D.AZT IS unsafe throughout pregnancy
• E. EFZ Is teratogenic hence avoid in 1st trimester
![Page 4: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/4.jpg)
CURRENT TREND IN MANAGEMENT OF
MATERNAL TO CHILD TRANSMISSION OF HIV
BY DR ZAINAB ABDULAZEEZ UMAR
DEPARTMENT OF FAMILY MEDICINE
![Page 5: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/5.jpg)
SYNOPSIS
• OBJECTIVES
• INTRODUCTION
• SCOPE OF HIV
• MTCT
• PMTCT
• HAART AND PMTCT
• INFANTS FEEDING
• CONCLUSION
• REFERENCES
![Page 6: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/6.jpg)
LEARNING OBJECTIVES
• To become familiar with factors affecting the transmission of HIV
from mother-to-child
• To become familiar with interventions to prevent the transmission of HIV from mother-to-child
• To be familiar with current guidelines in managing MTCT
![Page 7: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/7.jpg)
INTRODUCTION
• HIV the aetiological agents of AIDS have been identified as HIV-1 and HIV-2. These viruses belong to the Lentivirus group of Retroviridae family.
• HIV continues to be a major global public health issue, having claimed more than 36 million lives so far.
• The Human Immunodeficiency Virus (HIV) targets the immune system and weakens people's surveillance and defense systems against infections and some types of cancer.
![Page 8: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/8.jpg)
• As the virus destroys and impairs the function of immune cells, infected individuals gradually become immunodeficient
• Immunodeficiency results in increased susceptibility to a wide range of infections and diseases that people with healthy immune systems can fight off
• . The most advanced stage of HIV infection is Acquired Immunodeficiency Syndrome (AIDS), which can take from 2 to 15 years to develop depending on the individual
• . AIDS is defined by the development of certain cancers, infections, or other severe clinical manifestations
![Page 9: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/9.jpg)
• The transmission of HIV from an HIV-positive mother to her child during pregnancy, labour, delivery or breastfeeding is called mother-to-child transmission.
• In the absence of any interventions transmission rates range from 15-45%.
• This rate can be reduced to levels below 5% with effective interventions.
• These can be achieved by setting global norms and standards for HIV prevention, care and treatment of pregnant women, mothers and their children,
![Page 10: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/10.jpg)
•SCOPE OF HIV
![Page 11: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/11.jpg)
![Page 12: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/12.jpg)
WHO – HIV department | January 19, 2014|
The ranges around the estimates in this table define the boundaries within which the actual numbers lie, based on the best available information.
Regional HIV and AIDS statistics and features 2012
TOTAL 35.3 million[32.2 million – 38.8 million]
2.3 million[1.9 million – 2.7 million]
Adults and children newly infected with
HIV
Adults and children living with HIV
Sub-Saharan Africa
Middle East and North Africa
South and South-East Asia
East Asia
Latin America
Caribbean
Eastern Europe and Central Asia
Western and Central Europe
North America
Oceania
25.0 million[23.5 million – 26.6 million]
3.9 million[2.9 million – 5.2 million]
1.5 million[1.2 million – 1.9 million]
1.3 million[1.0 million – 1.7 million]
1.3 million[980 000 – 1.9 million]
1.6 million[1.4 million – 1.8 million]
270 000[160 000 – 440 000]
86 000[57 000 – 150 000]
130 000[89 000 – 190 000]
48 000[15 000 – 100 000]
260 000[200 000 – 380 000]
880 000[650 000 – 1.2 million]
250 000[220 000 – 280 000]
860 000[800 000 – 930 000]
51 000[43 000 – 59 000]
32 000[22 000 – 47 000]
81 000[34 000 – 160 000]
12 000[9400 – 14 000]
29 000[25 000 – 35 000]
2100[1500 – 2700]
1.6 million[1.4 million – 1.9 million]
Adult & child deaths due to AIDS
1.2 million[1.1 million – 1.3 million]
220 000[150 000 – 310 000]
52 000[35 000 – 75 000]
91 000[66 000 – 120 000]
20 000[16 000 – 27 000]
17 000[12 000 – 26 000]
41 000[25 000 – 64 000]
11 000[9400 – 14 000]
7600[6900 – 8300]
1200[<1000 – 1800]
0.8%[0.7% - 0.9%]
Adult prevalence (15‒49) [%]
4.7%[4.4% – 5.0%]
0.3%[0.2% – 0.4%]
0.4%[0.3% – 0.5%]
0.7%[0.6% – 1.0%]
0.5%[0.4% – 0.8%]
0.1%[0.1% – 0.2%]
<0.1%[<0.1% – 0.1%]
1.0%[0.9% – 1.1%]
0.2%[0.2% – 0.2%]
0.2%[0.2% – 0.3%]
![Page 13: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/13.jpg)
with nearly 1 in every 20 adults living with HIV. 69% of all people living with HIV are living in this region.
![Page 14: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/14.jpg)
New HIV infections have fallen by 33% since 2001.
![Page 15: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/15.jpg)
![Page 16: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/16.jpg)
, down from 3.4 New HIV infections among children have declined by 52% since 2001.
![Page 17: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/17.jpg)
![Page 18: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/18.jpg)
SCOPE IN NIGERIA
• HIV Prevalence in Nigeria is 4.6%
• Nigeria now has the second highest number of plwhiv in the world after South Africa.
• Over 90% of HIV infection in children are as a result of MTCT.
• An estimated 220,000 exposed children born each year.
• Without PMTCT about 88,000(40%) of these are infected.
• With PMTCT about 2% (4,400) infected.
• Nigeria has 30% of the global burden of MTCT.
![Page 19: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/19.jpg)
SCOPE IN KANO
In 2009 with 372 HIV infected pregnant women detected out of 3470 ANC clients
There were 4922 deliveries out of which 125 were HIV positive, giving a prevalence rate of 2.54%.
the transmission rate from mother to child amongst those who accessed PMTCT services was about 2-3 % .
![Page 20: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/20.jpg)
SCOPE OF HIV/AIDS IN WOMEN
HIV spreads rapidly, particularly among young women.
These women are in their most productive and reproductive years.
There are various factors that make women vulnerable to HIV infection, These factors include: Biological factors Socio-cultural factors
![Page 21: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/21.jpg)
BIOLOGICAL FACTORS
• Women have larger surface area of the genital mucosa
• Semen infected with HIV contains higher concentrations of virus than vaginal fluid.
• Young women have immature cervix and scanty vaginal secretion hence barrier to infection is reduced
• Women become more vulnerable again after menopause
• Tearing and bleeding during intercourse further increased predisposition to infection. This can occur during rough vagina sex, anal sex, dry sex or rape
• Untreated STIs multiplies the risk of HIV infection by 300-400%.
![Page 22: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/22.jpg)
SOCIO-CULTURAL FACTORS
• Economic and societal approved dependency on men
• Rights of women are abused and often violated.
• Condom use by stable partners is often frowned at.
• Cultural practices often expose women to multiple partners e.g polygamy, widow inheritance, wife hospitality
• Gender inequalities which negatively impacts on and their effect on seeking care and prevention efforts
• Burden of being the care provider in the home may supercede the need to care for herself
![Page 23: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/23.jpg)
Mother to Child Transmission of HIV Infection
![Page 24: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/24.jpg)
MOTHER-TO-CHILD TRANSMISSION
MTCT of HIV can occur during:• Pregnancy• Labour and delivery• Breastfeeding
![Page 25: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/25.jpg)
MOTHER-TO-CHILD TRANSMISSION
100 infants born to HIV-infected women who breastfeed, without any interventions
60 to 75 infants will not be HIV-infected
25–40 infants will be HIV-infected
5–10 infants infected during
pregnancy
About 15 infants
infected during labour and delivery
5–15 infants infected during breast-feeding
![Page 26: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/26.jpg)
• Pregnancy ---------- (5 - 10%)
• Delivery ------- (10 -15%)
• Breastfeeding ----- (10 - 15%)
Timing of Transmission: Targeting Prevention (In an Untreated Non-Breastfeeding Population, Total Transmission Rate is up to 25%)
![Page 27: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/27.jpg)
RISK FACTORS FOR MTCT
Pregnancy
•High maternal viral load
•Infection
•STIs
•Malnutrition
•Haemorrhage
Labour and Delivery
•High maternal viral load
•Prolonged rupture of membranes
•Invasive delivery procedures
•Chorioamnionitis
Breastfeeding
•High maternal viral load
•Duration
•Early mixed feeding
•Breast fissures, infections
•Poor maternal nutrition
•Oral disease in infant
![Page 28: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/28.jpg)
PMTCT
Prevention
Of
Mother
To
Child
Transmission
• Best practice for antenatal, intrapartum and postpartum care of the HIV-positive mother to reduce mother-to-child transmission
![Page 29: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/29.jpg)
ELEMENTS OF A SUCCESSFUL PROGRAMME FOR PREVENTION OF HIV INFECTION IN INFANTS AND YOUNG CHILDREN
• Element 1 Primary prevention of HIV infections
• Element 2 Prevention of unintended pregnancies among women infected with HIV
• Element 3 Prevention of HIV transmission from women infected with HIV to their infants
• Element 4 Provision of treatment, care and support to women infected with HIV, their infants and their families
![Page 30: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/30.jpg)
ABCs of primary HIV prevention for parents-to-be:
A = Abstain B = Be faithful to one HIV-uninfected partner C = Condom use – use condoms consistently and correctly
Adapt approach to local culture and target groups at risk
ELEMENT 1: PREVENTION OF PRIMARY HIV INFECTION
![Page 31: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/31.jpg)
• Access to counselling and referral for family planning
• Safe, consistent, effective contraception
ELEMENT 2: PREVENTION OF UNINTENDED PREGNANCIES AMONG WOMEN INFECTED WITH HIV
![Page 32: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/32.jpg)
Core Interventions
• HIV testing and counselling
• Antiretrovirals
• Safer delivery practices
• Safer infant-feeding practices
Combination interventions can reduce the MTCT rate to as low as 2% in the absence of breastfeeding.
ELEMENT 3: PREVENTION OF HIV TRANSMISSION FROM WOMEN INFECTED WITH HIV TO THEIR INFANTS
![Page 33: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/33.jpg)
• Prevention and treatment of OIs
• ARV treatment
• Treatment of symptoms
• Palliative care
• Nutritional support
• Reproductive healthcare
• Psychosocial and community support
ELEMENT 4: TREATMENT, CARE AND SUPPORT FOR WOMEN INFECTED WITH HIV AND THEIR FAMILIES
![Page 34: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/34.jpg)
SPECIFIC INTERVENTIONS TO REDUCE MOTHER-TO-CHILD TRANSMISSION
• HIV testing and coucelling in pregnancy• Antenatal care• Antiretroviral agents• Obstetric interventions
• Avoid amniotomy• Avoid procedures: Forceps/vacuum extractor, scalp electrode, scalp blood
sampling• Restrict episiotomy• Elective cesarean section• Remember infection prevention practices
• Newborn feeding: Breast milk vs. formula34
![Page 35: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/35.jpg)
TESTING AND COUNSELING FOR PMTCT
• Offered in the following settings• Antenatal care• Labour and delivery• Postnatal• Family planning and other services
• Information offered are the following:• HIV Infection and mode of transmission• Safer sex practices• Prevention and treatment of sexually transmitted infections (STIs)• Prevention of HIV in infants and young children including interventions for PMTCT• HIV testing, post-test counseling, and follow-up services
![Page 36: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/36.jpg)
• INFORMATIO OFFERED TO HIV +VES (POST TEST)
• Antiretroviral treatment/prophylaxis• Infant-feeding counseling and support• Information and counseling on family planning• Receive education on the importance of delivering in a setting where universal precautions and
safer obstetric practices are implemented. • Secure early access to HIV treatment, care and support services. • Receive information and counseling on the prevention of HIV transmission to others. • Receive follow-up and ongoing health care for themselves and their HIV-exposed infants. • Disclose their results to partners and family members.
![Page 37: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/37.jpg)
LAB. TESTING FOR HIV INFECTIONS
• Detectable components or products of viral infection for diagnosis• Antibodies-
• Rapid tests
• ELISA(reactive/non-reactive),
• Western blot (positive, negative, Indeterminate.)
• Antigen- antigen P24
• Nucleic acid- polymerase chain reaction
• Whole(viable)virus- viral culture
![Page 38: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/38.jpg)
LABORATORY TESTING(4)
CD4 lymphocyte count.
• Normal laboratory ranges 500-1400/mm.• Most useful for assessing immune function. • Degree of immuno-suppression determines staging of HIV infection, recommendations for ARV and prophylaxis
against OIs.
Viral Load estimation• goal is to reduce viral load to undetectable (<400 copies/mL)
![Page 39: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/39.jpg)
OTHER TESTS: BASELINE LABS TESTS
• FBC (anemia with ZDU)
• LFTs (mitochondrial disease with NRTI, elevated ALT w/ NNRTI and PI)
• amylase (pancreatitis with NRTI)
• early 1-hr OGT (GDM with PI)
• creatinine
• Hep B & C, CMV, toxo
![Page 40: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/40.jpg)
ANTENATAL CARE
• Most HIV-infected women will be asymptomatic• Watch for signs/symptoms of AIDS and pregnancy-related complications• Treat STDs and other coinfections• Counsel against unprotected intercourse• Avoid invasive procedures and external cephalic version• Give antiretroviral agents• Counsel about nutrition
HIV and Pregnancy 40
![Page 41: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/41.jpg)
Clinical Stage 1
Asymptomatic
Clinical Stage 2
Mild Disease
Stage 3 Advanced Disease Stage 4 Severe Disease (AIDS)
No symptoms or only: Persistent generalized lymphadenopathy
Weight loss 5-10%** Sores or cracks around
lips (angular cheilitis) Itching rash
(seborrhoea or prurigo)
Herpes zoster Recurrent upper
respiratory infections such as sinusitis or otitis
Weight loss > 10%** Oral thrush (or hairy
leukoplakia) More than 1 month: Diarrhoea or Unexplained fever Severe bacterial
infections (pneumonia, muscle infection, etc)
Pulmonary TB TB lymphadenopathy
HIV wasting syndrome Oesophageal thrush More than 1 month: Herpes simplex
ulcerations Recurrent severe
pneumonia within 6 months
Lymphoma* Kaposi sarcoma Invasive cervical cancer* CMV retinitis* Pneumocystis pneumonia Extrapulmonary TB* Toxoplasma* Cryptococcal meningitis* Visceral leishmaniasis*
If CD4 < 350 Cotrimoxazole & INH prophylaxis
If CD4 < 350 Cotrimoxazole & INH prophylaxis
Cotrimoxazole & INH prophylaxis
Cotrimoxazole & INH prophylaxis
Consider ART if CD4 < 350 Consider ART if CD4 < 350 ART ART
WH O A D U LT H IV C L IN IC A L S T A G IN G
![Page 42: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/42.jpg)
Principles of ARV useStrict adherence critical but a challenge in pregnancyARVs have side effects that need clinical and lab
monitoringBeware of drug interactionsResistance may develop if adherence is not excellent or
if drug interactions affect drug levels, resistance may occurResistance may be spread to baby and to partner
With excellent adherence and monitoring, risks of ARV are minimised and benefits are maximised
![Page 43: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/43.jpg)
HIV IN PREGNANCY: DRUG TREATMENT
• The goal in pregnancy is to reduce viral load to undetectable to minimize perinatal transmission.
• However, the woman should be counselled and willing to adhere to the regimen
• She should be counselled on the risks and benefits of the ARVs
![Page 44: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/44.jpg)
Evolution of the efficacy of the ARV prophylaxis: 1994-2004
0
5
10
15
20
25
30
35
None &BF
None noBF
NVP &BF
AZT36wks &
BF
AZT36wksno BF
AZT28wksno BF
AZT28wks +NVP no
BF
HAARTno BF
HAART+ C-S no
BF
% Transmission
Tran
smis
sion
Rat
e (%
)
![Page 45: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/45.jpg)
![Page 46: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/46.jpg)
NRTI NNRTI PI
Nucleoside reverse transcriptase inhibitors (NsRTI)
Nucleotide reverse transcriptase inhibitor (NtRTI)
Non-nucleoside reverse transcriptase inhibitors (NNRTI)
Protease Inhibitors (PI)
zidovudine (AZT) lamivudine (3TC)abacavir (ABC)emtricitabine (FTC) stavudine (d4T)
tenofovir disoproxil fumarate (TDF)
nevirapine (NVP)efavirenz (EFV)
saquinavir (SQV) ritonavir (RTV), as booster* indinavir (IDV) nelfinavir (NFV) lopinavir (LPV)
THE DIFFERENT ANTIRETROVIRAL DRUGS
![Page 47: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/47.jpg)
OTHERS
Fusion Inhibitor Enfuvirtide (ENF, T-20)
CCR5 Antagonist Maraviroc (MVC)
Integrase Inhibitor Raltegravir (RAL)
![Page 48: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/48.jpg)
• A first-line regimen is a combination of drugs that will be used in a patient who has no prior ART experience. This means that the patient has never taken ARV drugs before.
• Most commonly, a first-line regimen will consist of two NsRTI's and one NNRTI.
• Many patients will eventually develop failure of therapy: the first-line therapy will not be effective anymore (often because the drugs were not taken correctly). In that case, the doctor may decide to switch to a second-line regimen.
• Usually, the second-line regimen will consist of 2 NRTI + 1 PI.
FIRST - LINE AND SECOND-LINE REGIMEN
![Page 49: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/49.jpg)
![Page 50: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/50.jpg)
ART should be initiated in all pregnant women based on the following criteria.
• CD4 count of less than or equal to 350 irrespective of WHO clinical staging.
• WHO stages III and IV irrespective of CD4 cell count.• Nigerian guideline Recognizes pregnancy as an indication for
prophylactic ART irrespective of CD4 count, viral loads or clinical staging
ART INITIATION
![Page 51: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/51.jpg)
Women With CD4 Count above 350 Cells/mm3
Women With CD4 Count beloW 350 Cells/mm3
ChilD receives
option a During pregnancy: AZT starting as early as 14 weeks of pregnancy At delivery: single-dose NVP and first dose of AZT/3TC After delivery: daily AZT/3TC through 7 days postpartum
Triple ARVs started as soon as diagnosed and continued for life
Daily prophylaxis (NVP) from birth until 1 week after all breastfeeding has finished; or, if not breastfeeding or if mother is on treatment, through age 4–6 week
Option b Triple ARVs starting as early as 14 weeks of pregnancy continued through childbirth (if not breastfeeding) or until 1 week after all breastfeeding has finished
Daily prophylaxis (NVP or AZT) from birth through age 4–6 weeks regardless of infant feeding method
Option b+ Triple ARVs started as soon as diagnosed and continued for life
![Page 52: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/52.jpg)
Advantages of Option B+• Further simplification of regimen and service delivery (One regimen See
and Treat) • Harmonization with ART programmes (TDF + 3TC or FTC + EFV as first
line regardless of CD4 count)• Protection against mother-to-child transmission in future pregnancies• Continuing prevention benefit against sexual transmission to
serodiscordant partners• Avoiding stopping and starting of ARV drugs• HBV Co-infection therapy
![Page 53: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/53.jpg)
CHOICE OF ARV”S IN PREGNANCY
Combination regimens, usually including 2 NRTIs with either a NNRTI or 1 or more protease inhibitors (PIs) are recommended
AZT + 3TC + EFV/NVPAZT + 3TC (or FTC) + EFV/NVP
AZT + 3TC + LPV/rAZT + 3TC + ABCTDF + 3TC (or FTC) + EFV/NVP
![Page 54: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/54.jpg)
NOTE
Nevirapine is avoided in women with CD4 count >250. EFV is avoided in the first trimester
• Any pregnancy regimen should include ZDT unless contraindicated
• Combination HAART (3 drugs) is associated with vertical transmission rates of <2% and is considered standard of care (regardless of VL or CD4+)
• Safety of HAART in pregnancy is reassuring
• Continue drugs during labor
![Page 55: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/55.jpg)
NEW RECOMMENDATIONS IN WHO ART GUIDELINES (2013)
• • Earlier initiation of ART (CD4 ≤ 500)
• • 1) Immediate ART for children below 5 years
• • 2) Harmonization of ART across populations (e.g., adults and pregnant women, B/B+) and age groups
• • 3) Simplified, fewer, and less toxic 1st line regimens (TDF/3TC/EFV)
• • 4) Improved patient monitoring to support adherence and detect failure (increased use of VL)
• • 5) Recommend task shifting, decentralization, and integration
![Page 56: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/56.jpg)
TARGETS FOR E-MTCT
![Page 57: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/57.jpg)
CLINICAL SCENARIO 1:PREGNANT WOMAN HAS RECEIVED ARV MEDICATION IN THE PAST BUT IS NOT CURRENTLY ON ANY MEDICATION
• the choice of regimen may vary according to the history of prior use, the indication for stopping treatment in the past, gestational age, and resistance testing
• if there is no resistance to the drugs, ARV(HAART) can be used again, but avoid drugs with teratogenic potential or adverse maternal effects.
• Commence ARVS as soon as possible(AZT+3TC+NVP/EFZ) OR TDF
![Page 58: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/58.jpg)
CLINICAL SCENARIO II:PATIENT WHO IS ON A HAART REGIMEN PRESENTS FOR PRENATAL CARE
• continuing her treatment during the first trimester is reasonable,• Zidovudine should be a component of the regimen whenever
possible • provided that care is taken to avoid medications that are
contraindicated in early pregnancy
![Page 59: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/59.jpg)
CLINICAL SCENARIO III:ARV NAÏVE HIV-INFECTED PREGNANT WOMAN
• 1.In facility with capacity to provide and monitor triple ARV
• HAART should be started as soon as possible, including during the first trimester.
• Infant:dly NVP irrespective of feeding option
![Page 60: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/60.jpg)
CONT IIIB• 2.In facility with limited capacity to provide &
monitor triple ARVSThe following ARV prophylactic regimen is
recommended: Zidovudine from 14 weeks gestation.Sd NVP at onset of labourAZT+3TC during labour and deliveryAZT+3TC for 7 days post partum
![Page 61: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/61.jpg)
PROPHYLAXIS FOR PMTCT CLINICAL SETTING IIIB :THE INFANT
• A For breastfeeding infants: Commence daily NVP and continue until one week after cessation of all breastfeeding.
• B For non-Breastfeeding infants: Give daily NVP for 6 weeks only
![Page 62: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/62.jpg)
CLINICAL SCENARIO IV:HIV +VE DIAGNOSED IN LABOR
1. For facilities with capacity to provide and monitor Triple ARV medication:
Mother Commence triple ARV prophylaxis during labour and continue thru bf2. For facilities with limited capacity (on–site or by linkage) to provide and monitor triple ARV
medication.
Mother:
• Intrapartum:
sdNVP + ZDV + 3TC as soon as diagnosis is made in labour.
• Post partum:
ZDV + 3TC for 7 days
• Determine if mother is eligible (within 5 days of delivery) for HAART
![Page 63: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/63.jpg)
Infant:
• Mother breastfeeding not commenced on HAART:
Give daily NVP to infants from birth until one week after cessation of all breastfeeding
• Mother breastfeeding (eventually commenced on HAART) Give daily NVP to infants from birth and continue until six weeks after maternal
commencement of HAART
• Mother not breastfeeding: Give daily NVP to infants from birth until 6 weeks of age.
![Page 64: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/64.jpg)
CLINICAL SETTING VRECOMMENDATIONS FOR PREGNANT HIV-SEROPOSITIVE MOTHERS WHO PRESENT AFTER DELIVERY
If mother chooses to breastfeed, recommend HAART (follow guidelines for HAART eligible mothers)
If mother chooses to formula feed, determine if mother is eligible for HAART for her own disease,
Infant :give sdnvp and then for 6 wks
![Page 65: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/65.jpg)
CLINICAL SETTING VI: HIV-INFECTED WOMAN WITH ACTIVE TB
• Delay ARV treatment until second trimester, if possible.
Treatment regimens: These are in decreasing order of preference
• If treatment is initiated in second trimester EFV (800mg) + 2NRTIs
ZDV + 3TC + Abacavir
2 NRTIs + Ritonavir-boosted PI* (Saquinavir/r or Lopinavir/r) ZDV + 3TC + Tenofovir
Change rifampin to low dose rifabutin
INFANTS:Prophylactic INH from birth (5mg/Kg once daily) until six (6) months of age
![Page 66: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/66.jpg)
WHO PROGRAMMATIC UPDATE APRIL 2012
• Option B+: – Triple ARV drugs to all HIV-infected pregnant women beginning
in the antenatal clinic setting and continuing this therapy for all of these women for life.
• Now being considered by the PMTCT Task Team
![Page 67: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/67.jpg)
NATIONAL RECOMMENDATIONS 2010INFANTS
• HIV+ Mothers ( whose infants are HIV uninfected or of unknown HIV status) should exclusively breastfeed their infants for the first 6 months of life, introducing appropriate complementary foods thereafter, and continue breastfeeding for the first 12 months of life.
Breastfeeding should then only stop once a nutritionally adequate and safe diet without breast milk can be provided.
When HIV-infected mothers decide to stop breastfeeding (at any time) they should do so gradually within one month
![Page 68: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/68.jpg)
: MONITORING OF THERAPY • Check viral load, CD4+, LFTs, FBC every trimester• Consider change of therapy if viral load still detectable in 3-6
months• Exclude adherence problems
• Is she taking her meds??
• Baseline ARV resistance testing • HAART naïve (new) cases• HAART re-starts• if suboptimal viral suppression
![Page 69: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/69.jpg)
CARE IN LABOUR AND DELIVERY
• AVOID ARM/FETAL SCALP PROCEDURES/ECV• UNIVERSAL PRECAUTIONS SHOULD BE APPLIED• AVOID ROUTINE EPISIOTOMY• FORCEPS PREFERABLE TO VACUUM• ELECTIVE C/S BENEFICIAL• Elective Caesarean section (C/S) reduces the risk of MTCT
by at least 50% compare with vaginal delivery
![Page 70: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/70.jpg)
![Page 71: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/71.jpg)
• Following delivery, avoid milking the cord. • The baby should be thoroughly dried, and any remaining maternal
blood and amniotic fluid should be removed.• Vigorous suctioning of the infant’s mouth and pharynx should be
avoided• Vaginal cleansing using disinfectants such as chlorhexidine where
SVD is anticipated.• Use partogram to monitor labour progress.• Determine mother’s feeding choice
![Page 72: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/72.jpg)
INFANT FEEDING OPTIONS
Allow mother to take decision by her self after counselling.Exclusive Breast feeding
1 Support mother, put baby to breast immediately, exclusive, proper position & attachment, feed on demand2 Modification of BF a Early cessation- stop by 6 mths.b Expressing & heat treating BM.c Wet nursing- not advisable.
![Page 73: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/73.jpg)
• EXCLUSIVE FORMULAR FEEDING
A- acceptable.
F- feasible.
A- affordable.
S- sustainable.
S- safe.
Types –commercial infant formula & home made modified animal milk.
![Page 74: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/74.jpg)
![Page 75: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/75.jpg)
COMPREHENSIVE POSTPARTUM CARE AND SUPPORT
Components of comprehensive care include the following medical and supportive care services:• Primary, obstetric, paediatric and HIV specialty care• Family planning services• Immunization/prophylaxis against OIs• Mental health services• Substance-abuse treatment• Coordination of care through case management for the woman, her children, and other
family members.
![Page 76: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/76.jpg)
Support services should include case management childcare, respite care, assistance with basic life needs (eg. housing, food,
and transportation), and legal and advocacy services. Continuity of antiretroviral treatment must be
ensured.
![Page 77: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/77.jpg)
ROLE OF FAMILY PHYSICIAN
• HIV IS ONE DISEASE THAT ALLOWS THE FAMILY PHYSICIAN TO PRACTICE WITH ALL HIS SKILLS
-COUNSELING\EDUCATING
-PERSONALISED CARE
-CONTINOUS CARE
-FAMILY CARE
-TEAM WORK\REFERRAL ETC
![Page 78: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/78.jpg)
CONCLUSION
PMTCT is a success story in HIV prevention.A proper understanding of the basic principles of HIV
and ARV use is all that is necessary to achieve this success.
The implementation of the core PMTCT interventions based on these principles will reduce MTCT from 40% to about 2%.
![Page 79: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/79.jpg)
THANK YOU FOR YOUR ATTENTION
![Page 80: PRE-TEST 1.Regargind latest guideline on initiation of ARV start at CD4 of A. 200cc/ml C.. Publish Valentine Page, Modified 4 months ago](https://reader038.vdocuments.mx/reader038/viewer/2022110403/56649e615503460f94b5c22e/html5/thumbnails/80.jpg)
REFERENCES
• British HIV Association guidelines for the management of HIV infection in pregnant women 2012
• National guidelines on PMTCT 2010
• National guidelines on PMTCT 2012
• H Galadanci et al Outcome of deliveries among HIV +ve mothers at AKTH – NJM 2006.
• Infant feeding in HIV – generic training manual.
• Expanding and Simplifying Treatment for Pregnant Women Living with HIV
• HIV in pregnancy www.medscape.com/hiv in pregnancy
• WHO Guideline on PMTCT
• AITT option b+ Toolkit 2013 expanding and simplifying treatment for pregnant women www.emtct.iatt.org
• V Mangiaterra WHO: Global plan to eliminate MTCT of HIV 2013